Protective effects of GuanXinNing tablet (GXNT) on diabetic encephalopathy in zucker diabetic obesity (ZDF) rats.

BMC Complement Med Ther · 2023 · PMC10605859 · PMID 37891536

Europe PMC DOI

hedged sentences

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Compared to the model group, both the 300 mg/kg and 600 mg/kg GXNT treatment groups showed a highly significant increase in the number of microvessels and neurons (p < 0.01) (Fig. 8 c, d, f, g), while the Met treatment group showed no significant change in the number of neurons (p > 0.05) but exhibited a highly significant increase in the number of microvessels (p < 0.01) (Fig. 8 e, f, g).

also in 132,142 other papers

a decreasing trendno p-value reported

Relative to the model group, both the GXNT and Met groups of rats showed a decreasing trend in postprandial blood glucose and HbA1c levels.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.